| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| sEphB4-HSA | Vas-01; sEphB4-HSA | Phase 2 Clinical | Vasgene | Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Kaposi; Carcinoma, Non-Small-Cell Lung; Gallbladder Neoplasms; Leukemia, Myeloid, Acute; Philadelphia Chromosome; Bile Duct Neoplasms; Prostatic Neoplasms; Sarcoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic; Prostatic Neoplasms, Castration-Resistant; Urinary Bladder Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Leukemia, Lymphoid; Solid tumours; Bone Marrow Neoplasms | Details |